MECP2 and Alzheimer disease: A study by Huang et al. showed that MeCP2 mRNA expression was downregulated in the hippocampus of AD patients [31], whereas a study by Lee et al. showed that MeCP2 protein levels were upregulated in the forebrain (putamen and cortex) of AD patients [99].